Form 10-K Viridian Therapeutics, For: Dec 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to Form 10-K Viridian Therapeutics, For: Dec 31

Stifel on Viridian Therapeutic (VRDN): 'We think shares can trade in the $40+ range'

February 26, 2026 2:58 PM EST

Stifel analyst Alex Thompson reiterated a Buy rating and $48.00 price target on Viridian Therapeutic (NASDAQ: VRDN)

The analyst comments "We are reiterating our Buy Rating on VRDN following its 4Q25 report. The Veligrotug BLA is under priority review for a target PDUFA... More